Literature DB >> 7648352

Treatment of the antiphospholipid syndrome.

J C Piette1, M Karmochkine, T Papo, L T Du, C Francès, B Wechsler.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7648352     DOI： 10.1007/BF02772251

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  95 in total

1.  In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism.

Authors:  M Galli; S Cortelazzo; T Barbui
Journal:  Am J Hematol       Date:  1991-11       Impact factor: 10.047

2.  Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria.

Authors:  J C Piette; B Wechsler; C Francis; P Godeau
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

3.  Plasma exchange and the anticardiolipin syndrome in pregnancy.

Authors:  D Fulcher; G Stewart; T Exner; B Trudinger; R Jeremy
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

Review 4.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

5.  Hypertension and the antiphospholipid antibodies.

Authors:  R A Asherson; M A Khamashta; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1993 Sep-Oct       Impact factor: 4.473

6.  [Hematologic forms of lupus erythematosus disseminatus with and without antinuclear factors. 25 case reports].

Authors:  O Blétry; A Mathieu; J C Piette; O Meyer; J Conard; B Wechsler; P Godeau
Journal:  Rev Med Interne       Date:  1983-03       Impact factor: 0.728

7.  Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  Y Ishii; K Nagasawa; T Mayumi; Y Niho
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 8.  The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE.

Authors:  D J Wallace; M Linker-Israeli; A L Metzger; V J Stecher
Journal:  Lupus       Date:  1993-02       Impact factor: 2.911

9.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

10.  Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin.

Authors:  L H Silveira; C L Hubble; L J Jara; S Saway; P Martínez-Osuna; M J Seleznick; J Angel; W O'Brien; L R Espinoza
Journal:  Am J Med       Date:  1992-10       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.